Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-26 5:26 pm Sale | 2021-01-22 | 13D | Infinity Pharmaceuticals, Inc. INFIQ | BIOTECHNOLOGY VALUE FUND L P | 10,726,968 16.700% | -6,700,000 (-38.45%) | Filing History |
| 2021-01-19 5:21 pm Purchase | 2021-01-06 | 13G | Aileron Therapeutics, Inc. ALRN | BIOTECHNOLOGY VALUE FUND L P | 13,164 6.300% | 13,164 (New Position) | Filing History |
| 2021-01-14 4:48 pm Sale | 2021-01-12 | 13G | AC Immune S.A. ACIU | BIOTECHNOLOGY VALUE FUND L P | 7,916,658 11.000% | -3,425,847 (-30.20%) | Filing History |
| 2021-01-13 4:56 pm Sale | 2021-01-11 | 13G | Cytokinetics, Incorporated CYTK | BIOTECHNOLOGY VALUE FUND L P | 2,728,035 3.900% | -4,629,984 (-62.92%) | Filing History |
| 2021-01-12 5:10 pm Unchanged | 2021-01-08 | 13D | PHAXIAM Therapeutics S.A. PHXM | BIOTECHNOLOGY VALUE FUND L P | 44,619 22.300% | 0 (Unchanged) | Filing History |
| 2021-01-11 5:06 pm Purchase | 2020-12-30 | 13G | GRITSTONE BIO INC GRTSQ | BIOTECHNOLOGY VALUE FUND L P | 2,695,418 6.500% | 2,695,418 (New Position) | Filing History |
| 2020-12-30 5:27 pm Purchase | 2020-12-28 | 13G | NOVUS THERAPEUTICS INC NVUS | BIOTECHNOLOGY VALUE FUND L P | 1,518,039 10.000% | 3,520 (+0.23%) | Filing History |
| 2020-12-28 5:13 pm Purchase | 2020-12-22 | 13G | NOVUS THERAPEUTICS INC NVUS | BIOTECHNOLOGY VALUE FUND L P | 1,514,519 9.990% | 1,319,193 (+675.38%) | Filing History |
| 2020-12-21 4:37 pm Purchase | 2020-12-11 | 13G | Lexicon Pharmaceuticals, Inc. LXRX | BIOTECHNOLOGY VALUE FUND L P | 10,963,000 7.800% | 10,963,000 (New Position) | Filing History |
| 2020-12-15 5:21 pm Unchanged | 2020-12-11 | 13D | XOMA Corporation XOMA | BIOTECHNOLOGY VALUE FUND L P | 4,182,243 37.900% | 0 (Unchanged) | Filing History |
| 2020-12-10 5:16 pm Sale | 2020-02-04 | 13G | Arcus Biosciences, Inc. RCUS | BIOTECHNOLOGY VALUE FUND L P | 2,752,222 4.200% | -826,801 (-23.10%) | Filing History |
| 2020-11-20 5:23 pm Purchase | 2020-11-19 | 13D | Olema Pharmaceuticals, Inc. OLMA | BIOTECHNOLOGY VALUE FUND L P | 6,661,503 16.600% | 6,661,503 (New Position) | Filing History |
| 2020-11-16 5:29 pm Purchase | 2020-11-12 | 13G | Cytokinetics, Incorporated CYTK | BIOTECHNOLOGY VALUE FUND L P | 7,358,019 10.400% | 3,419,739 (+86.83%) | Filing History |
| 2020-11-13 5:27 pm Sale | 2020-11-11 | 13D | FIVE PRIME THERAPEUTICS INC FPRX | BIOTECHNOLOGY VALUE FUND L P | 1,263,678 3.300% | -7,100,675 (-84.89%) | Filing History |
| 2020-11-12 5:13 pm Unchanged | 2020-11-09 | 13D | Infinity Pharmaceuticals, Inc. INFIQ | BIOTECHNOLOGY VALUE FUND L P | 17,426,968 27.100% | 0 (Unchanged) | Filing History |
| 2020-11-12 5:11 pm Purchase | 2020-11-09 | 13G | Calliditas Therapeutics AB (publ) CALT | BIOTECHNOLOGY VALUE FUND L P | 7,431,562 14.900% | 2,650,000 (+55.42%) | Filing History |
| 2020-11-10 4:58 pm Purchase | 2020-11-06 | 13G | CytomX Therapeutics, Inc. CTMX | BIOTECHNOLOGY VALUE FUND L P | 4,626,411 10.000% | 1,437,463 (+45.08%) | Filing History |
| 2020-11-09 5:26 pm Purchase | 2020-10-28 | 13G | MIRAGEN THERAPEUTICS INC MGEN | BIOTECHNOLOGY VALUE FUND L P | 7,584,219 9.990% | 7,584,219 (New Position) | Filing History |
| 2020-11-03 4:39 pm Sale | 2020-10-30 | 13G | BioLineRx Ltd. BLRX | BIOTECHNOLOGY VALUE FUND L P | 148,671 1.900% | -632,391 (-80.97%) | Filing History |
| 2020-10-20 08:59 am Purchase | 2020-05-22 | 13G | ContraFect Corporation CFRX | BIOTECHNOLOGY VALUE FUND L P | 36,361 9.990% | 36,361 (New Position) | Filing History |